A cutting-edge research presentation on the Biocompatibility and Tissue Regeneration Ability of DuraBeam®, the artificial dura mater, will be given by Dr. Tomohito Nagai, Department of Neurosurgery, Graduate School of Biomedical Engineering, Tohoku University Graduate School of Medicine, at The 18th Annual Meeting of the Japanese Society of Aesthetic Neurosurgery (JSAN2025, Chair: Professor Haruhiko Kijima, Department of Neurosurgery, Osaka University Graduate School of Medicine, April 18th (Fri) to April 19th (Sat), 2025, Osaka International Convention Center, Hall 4, Conference Room 1002, 9:35am after the JSAN opening ceremony, CNTT/JSAN joint oral presentation, Revolution in surgical materials).
https://site.convention.co.jp/jsan2025
https://site.convention.co.jp/cntt2025
For further details, please contact:
TamaBio Company Limited
Head Office : 402 Gran Creste 2-2-18 Sakai Musashino-shi Tokyo 180-0022 Japan
Medical device manufacturing / Class 1 manufacturing and sales Development
Manufacturing, and sales of Class IV highly controlled medical devices
Development, manufacturing, and sales of regenerative medical devices and other synthetic artificial biomembranes
Managing Director / CEO : Tetsuya Nagao
TEL : +81-422-53-5051 / FAX : +81-422-38-5091